Tests ATX304 safety in healthy adults with overweight or obesity
Tests ATX304, a new medicine, in healthy adults with overweight or obesity.
Plain-language title generated from the registry record
Registry title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX304
Key facts
- Where
- Neuss, GermanySee the site
- Phase
- Phase 1
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 64 years. It tests the safety and effects of ATX304 against a placebo.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Germany
- PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorTrial details
- Who runs it
- Betagenon AB
- Trial code
- EU 2024-514744-91-00
- Record updated
- 30 July 2026